Breaking news

Masayoshi Son’s Bold Vision: SoftBank at the Forefront of an AI Revolution


Vision And Strategy: Embracing Artificial Superintelligence

Masayoshi Son is betting big on a future defined by artificial superintelligence (ASI), a technology he envisions to be 10,000 times smarter than humans within the next decade. This audacious forecast, though bold, is consistent with Son’s established history of making transformative, high-stakes investments—most notably his early $20 million stake in Alibaba which has since generated substantial returns for SoftBank.

Transformative Investments And Strategic Acquisitions

SoftBank’s aggressive push into the AI domain is evident in its high-profile transactions. The acquisition of Arm in 2016 for approximately $32 billion, now valued at more than $145 billion, underscores the company’s ambition to be a pivotal player in AI-driven infrastructure. More recently, SoftBank announced plans to acquire Ampere Computing for $6.5 billion and has committed significant capital to OpenAI—a move that signals its determination to weave AI deeply into its corporate fabric.

Historical Boldness And The Art Of Timing

Son’s trajectory is defined by visionary risks, as seen in his early musings on ‘brain computers’ and robotics. Even though some ventures, such as the Pepper humanoid robot, did not meet expectations, these experiments laid the groundwork for a broader, long-term strategy. The early adoption of key technologies, despite occasional missteps, highlights SoftBank’s willingness to invest deeply for future payoff—even if market timing has sometimes proved challenging.

Balancing Risks With Reward In A Rapidly Evolving Landscape

Competition in AI is heating up globally, with major tech companies in the U.S. and China jockeying for position in the race towards artificial general intelligence (AGI). While the sector is inherently high-risk due to continuous technological evolutions and unexpected breakthroughs by rivals, SoftBank remains confident in its comprehensive, end-to-end strategy. Its portfolio, spanning semiconductors, software, robotics, and cloud services, is engineered to be resilient in the face of industry disruptions.

A Vision For The Future: Building A Legacy For Centuries

Son’s enduring ambition is nothing short of revolutionary; he envisions an AI-integrated future that will secure SoftBank’s relevance for the next 300 years. This long-term perspective, marked by significant investments and a readiness to make mistakes along the way, continues to fuel the company’s transformation into a cornerstone of the emerging AI ecosystem.


EU Records €220.5 Billion Pharmaceutical Trade Surplus In 2025

The European Union secured a historic trade surplus in medicinal and pharmaceutical products in 2025, according to a report from Eurostat. Export figures reached €366.2 billion while imports totaled €145.7 billion, leading to a surplus of €220.5 billion.

Robust Growth In Exports And Imports

Exports increased by 16.0% from €315.7 billion in 2024. Imports rose by 21.0% from €120.4 billion over the same period. The data show continued expansion in trade volumes across the sector.

Leading National Performances

Ireland recorded the highest exports to non-EU countries at €93.8 billion. Germany and Belgium followed with €67.9 billion and €38.5 billion, respectively. Italy led imports at €27.5 billion, with Belgium and Germany also recording significant volumes.

Global Trade Partnerships

The United States was the largest destination for EU exports, accounting for 43.8% or €160.6 billion. Switzerland followed with 16.3% (€59.7 billion), while the United Kingdom accounted for 5.6% (€20.6 billion). On the import side, the United States supplied 41.2% of total imports (€60.1 billion), followed by Switzerland at 28.4% (€41.4 billion) and China at 9.0% (€13.1 billion).

Aretilaw firm
The Future Forbes Realty Global Properties
eCredo
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter